210 related articles for article (PubMed ID: 19734449)
21. Over-expression of BACH2 is related to ongoing somatic hypermutation of the immunoglobulin heavy chain gene variable region of de novo diffuse large B-cell lymphoma.
Kikuchi T; Tokunaka M; Kikuti YY; Carreras J; Ogura G; Takekoshi S; Kojima M; Ando K; Hashimoto Y; Abe M; Takata K; Yoshino T; Muto A; Igarashi K; Nakamura N
Pathol Int; 2013 Jul; 63(7):339-44. PubMed ID: 23865571
[TBL] [Abstract][Full Text] [Related]
22. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
23. [SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].
Gavrilina OA; Zvonkov EE; Biderman BV; Severina NA; Parovichnikova EN
Ter Arkh; 2015; 87(7):105-111. PubMed ID: 26390734
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous B-cell lymphoma is associated with somatically hypermutated immunoglobulin variable genes and frequent use of VH1-69 and VH4-59 segments.
Perez M; Pacchiarotti A; Frontani M; Pescarmona E; Caprini E; Lombardo GA; Russo G; Faraggiana T
Br J Dermatol; 2010 Mar; 162(3):611-8. PubMed ID: 19906071
[TBL] [Abstract][Full Text] [Related]
25. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.
Hübschmann D; Kleinheinz K; Wagener R; Bernhart SH; López C; Toprak UH; Sungalee S; Ishaque N; Kretzmer H; Kreuz M; Waszak SM; Paramasivam N; Ammerpohl O; Aukema SM; Beekman R; Bergmann AK; Bieg M; Binder H; Borkhardt A; Borst C; Brors B; Bruns P; Carrillo de Santa Pau E; Claviez A; Doose G; Haake A; Karsch D; Haas S; Hansmann ML; Hoell JI; Hovestadt V; Huang B; Hummel M; Jäger-Schmidt C; Kerssemakers JNA; Korbel JO; Kube D; Lawerenz C; Lenze D; Martens JHA; Ott G; Radlwimmer B; Reisinger E; Richter J; Rico D; Rosenstiel P; Rosenwald A; Schillhabel M; Stilgenbauer S; Stadler PF; Martín-Subero JI; Szczepanowski M; Warsow G; Weniger MA; Zapatka M; Valencia A; Stunnenberg HG; Lichter P; Möller P; Loeffler M; Eils R; Klapper W; Hoffmann S; Trümper L; ; ; ; Küppers R; Schlesner M; Siebert R
Leukemia; 2021 Jul; 35(7):2002-2016. PubMed ID: 33953289
[TBL] [Abstract][Full Text] [Related]
26. Combination of two monoclonal antibodies with SOCS1 N- and C-terminal binding sites to address SOCS1 status in B cells and B-cell lymphoma.
Weissinger SE; Zahn M; Marienfeld R; Tessmer C; Moldenhauer G; Möller P
Eur J Haematol; 2022 Mar; 108(3):223-231. PubMed ID: 34854137
[TBL] [Abstract][Full Text] [Related]
27. Somatic hypermutation patterns in germinal center B cell malignancies.
Stamatopoulos K; Belessi C; Papadaki T; Stavroyianni N; Hadzidimitriou A; Kosmas C; Laoutaris N; Fassas A; Anagnostopoulos A
Hematology; 2003 Oct; 8(5):319-28. PubMed ID: 14530174
[No Abstract] [Full Text] [Related]
28. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.
Libra M; Capello D; Gloghini A; Laura P; Berra E; Cerri M; Gasparotto D; Franca S; De Re V; Gaidano G; Carbone A
J Pathol; 2005 May; 206(1):87-91. PubMed ID: 15809970
[TBL] [Abstract][Full Text] [Related]
29. Role of AID in tumorigenesis.
Okazaki IM; Kotani A; Honjo T
Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
[TBL] [Abstract][Full Text] [Related]
30. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a).
Gordon MS; Kanegai CM; Doerr JR; Wall R
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4126-31. PubMed ID: 12651942
[TBL] [Abstract][Full Text] [Related]
31. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
32. Somatic hypermutation and B-cell lymphoma.
Dunn-Walters D; Thiede C; Alpen B; Spencer J
Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
[TBL] [Abstract][Full Text] [Related]
33. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
Juskevicius D; Jucker D; Klingbiel D; Mamot C; Dirnhofer S; Tzankov A
J Hematol Oncol; 2017 Mar; 10(1):70. PubMed ID: 28302137
[TBL] [Abstract][Full Text] [Related]
34. A new reliable and highly specific monoclonal antibody to detect the C-terminal region of silencer of cytokine signaling 1.
Weissinger SE; Zahn M; Marienfeld R; Tessmer C; Moldenhauer G; Möller P
Eur J Haematol; 2021 Jul; 107(1):74-80. PubMed ID: 33714214
[TBL] [Abstract][Full Text] [Related]
35. Prognostic analysis of aberrant somatic hypermutation of RhoH gene in diffuse large B cell lymphoma.
Hiraga J; Katsumi A; Iwasaki T; Abe A; Kiyoi H; Matsushita T; Kinoshita T; Naoe T
Leukemia; 2007 Aug; 21(8):1846-7. PubMed ID: 17443219
[No Abstract] [Full Text] [Related]
36. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation.
Reiniger L; Bödör C; Bognár A; Balogh Z; Csomor J; Szepesi A; Kopper L; Matolcsy A
Leukemia; 2006 Jun; 20(6):1089-95. PubMed ID: 16541139
[TBL] [Abstract][Full Text] [Related]
37. The impact of SOCS1 mutations in diffuse large B-cell lymphoma.
Mellert K; Martin M; Lennerz JK; Lüdeke M; Staiger AM; Kreuz M; Löffler M; Schmitz N; Trümper L; Feller AC; Hartmann S; Hansmann ML; Klapper W; Stein H; Rosenwald A; Ott G; Ziepert M; Möller P
Br J Haematol; 2019 Dec; 187(5):627-637. PubMed ID: 31407320
[TBL] [Abstract][Full Text] [Related]
38. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
[TBL] [Abstract][Full Text] [Related]
39. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma.
Rossi D; Cerri M; Capello D; Deambrogi C; Berra E; Franceschetti S; Alabiso O; Gloghini A; Paulli M; Carbone A; Pileri SA; Pasqualucci L; Gaidano G
Leukemia; 2005 Dec; 19(12):2363-6. PubMed ID: 16208407
[No Abstract] [Full Text] [Related]
40. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
Montesinos-Rongen M; Van Roost D; Schaller C; Wiestler OD; Deckert M
Blood; 2004 Mar; 103(5):1869-75. PubMed ID: 14592832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
